Lineage Cell Therapeutics, Inc. · AMEX:LCTX

Lineage Cell Therapeutics, Inc. shareholders

As of Sep 30, 2026, 138 institutions reported holding Lineage Cell Therapeutics, Inc., 46.3% of its shares. Largest: Broadwood Capital Inc, BlackRock and Vanguard. New holders, exits, insiders and big stakes, each with its filing.

HolderShares% of Lineage Cell Therapeutics, Inc.ChangeFiled
Broadwood Capital Inc49.6M19.6%no changeNov 13, 2026
BlackRock13.9M5.5%+684KNov 13, 2026
Vanguard11.9M4.7%−194KNov 16, 2026
Defender Capital, LLC.6.65M2.6%+50,000Oct 1, 2026
Geode Capital5.34M2.1%+39,897Nov 6, 2026
Raffles Associates LP5.2M2.1%no changeNov 16, 2026
Fifth Third Bancorp4.9M1.9%+300KNov 5, 2026
State Street2.93M1.2%+612KNov 12, 2026
Millennium2.63M1.0%−390KNov 16, 2026
Northern Trust1.66M0.66%+1,004Nov 16, 2026

Lineage Cell Therapeutics, Inc. insider trades